- $399.54m
- $248.18m
- $123.39m
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 60.8 | 70.9 | 69.6 | 130 | 123 |
Cost of Revenue | |||||
Gross Profit | -18.5 | -7.72 | -15.6 | -29.6 | -10.5 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 128 | 108 | 147 | 274 | 244 |
Operating Profit | -66.9 | -37.4 | -77 | -144 | -121 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -77.5 | -89.1 | -101 | -146 | -107 |
Provision for Income Taxes | |||||
Net Income After Taxes | -77.6 | -89.1 | -101 | -147 | -108 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -77.6 | -89.1 | -101 | -143 | -108 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -100 | -92.4 | -104 | -146 | -111 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.65 | -0.422 | -0.288 | -0.378 | -0.284 |